Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Hepatitis C

  Free Subscription


Articles published in J Virol

Retrieve available abstracts of 101 articles:
HTML format
Text format



Single Articles


    August 2017
  1. KWON YC, Sasaki R, Meyer K, Ray R, et al
    HEPATITIS C VIRUS CORE PROTEIN MODULATES ENDOGLIN (CD105) SIGNALING PATHWAY FOR LIVER PATHOGENESIS.
    J Virol. 2017 Aug 9. pii: JVI.01235-17. doi: 10.1128/JVI.01235.
    PubMed     Text format     Abstract available


  2. PIERCE BG, Boucher EN, Piepenbrink KH, Ejemel M, et al
    Structure-Based Design of Hepatitis C Virus Vaccines that Elicit Neutralizing Antibody Responses to a Conserved Epitope.
    J Virol. 2017 Aug 9. pii: JVI.01032-17. doi: 10.1128/JVI.01032.
    PubMed     Text format     Abstract available


    July 2017
  3. KIM JY, Wang L, Lee J, Ou JJ, et al
    HCV induces the localization of lipid rafts to autophagosomes for its RNA replication.
    J Virol. 2017 Jul 26. pii: JVI.00541-17. doi: 10.1128/JVI.00541.
    PubMed     Text format     Abstract available


  4. YIN P, Li Y, Zhang L
    Sec24C-Dependent Transport of Claudin-1 Regulates Hepatitis C Virus Entry.
    J Virol. 2017 Jul 5. pii: JVI.00629-17. doi: 10.1128/JVI.00629.
    PubMed     Text format     Abstract available


    June 2017
  5. WELLER R, Hueging K, Brown RJP, Todt D, et al
    Hepatitis C virus strain-dependent usage of apolipoprotein E modulates assembly efficiency and specific infectivity of secreted virions.
    J Virol. 2017 Jun 28. pii: JVI.00422-17. doi: 10.1128/JVI.00422.
    PubMed     Text format     Abstract available


  6. BELOUZARD S, Danneels A, Feneant L, Seron K, et al
    Entry and release of hepatitis C virus in polarized human hepatocytes.
    J Virol. 2017 Jun 28. pii: JVI.00478-17. doi: 10.1128/JVI.00478.
    PubMed     Text format     Abstract available


  7. CEVIK RE, Cesarec M, Da Silva Filipe A, Licastro D, et al
    Hepatitis C virus NS5A targets the nucleosome assembly protein NAP1L1 to control the innate cellular response.
    J Virol. 2017 Jun 28. pii: JVI.00880-17. doi: 10.1128/JVI.00880.
    PubMed     Text format     Abstract available


  8. GOONAWARDANE N, Gebhardt A, Bartlett C, Pichlmair A, et al
    Phosphorylation of serine 225 in hepatitis C virus NS5A regulates protein-protein interactions.
    J Virol. 2017 Jun 14. pii: JVI.00805-17. doi: 10.1128/JVI.00805.
    PubMed     Text format     Abstract available


    May 2017
  9. WONG MT, Chen SS
    Hepatitis C Virus Subverts Human Choline Kinase-alpha to Bridge PI4KIIIalpha and NS5A and Upregulates PI4KIIIalpha Activation, Thereby Promoting the Translocation of the Ternary Complex to the ER for Viral Replication.
    J Virol. 2017 May 31. pii: JVI.00355-17. doi: 10.1128/JVI.00355.
    PubMed     Text format     Abstract available


  10. LI Z, Li Y, Bi Y, Zhang H, et al
    Extracellular Interactions between Hepatitis C Virus and Secreted Apolipoprotein E.
    J Virol. 2017 May 24. pii: JVI.02227-16. doi: 10.1128/JVI.02227.
    PubMed     Text format     Abstract available


  11. SYED GH, Khan M, Yang S, Siddiqui A, et al
    Hepatitis C virus lipoviroparticles (HCV-LVP) assemble in the endoplasmic reticulum (ER) and bud off from the ER to Golgi in COPII vesicles.
    J Virol. 2017 May 17. pii: JVI.00499-17. doi: 10.1128/JVI.00499.
    PubMed     Text format     Abstract available


  12. DEVHARE PB, Sasaki R, Shrivastava S, Di Bisceglie AM, et al
    Correction for Devhare et al., "Exosome-Mediated Intercellular Communication between Hepatitis C Virus-Infected Hepatocytes and Hepatic Stellate Cells".
    J Virol. 2017;91.
    PubMed     Text format    


    April 2017
  13. FILSKOV J, Mikkelsen M, Hansen PR, Christensen JP, et al
    Broadening CD4+ and CD8+ T cell responses against hepatitis C virus by vaccination with NS3 overlapping peptide panels in cross-priming liposomes.
    J Virol. 2017 Apr 26. pii: JVI.00130-17. doi: 10.1128/JVI.00130.
    PubMed     Text format     Abstract available


  14. HSU SC, Lo CW, Pan TC, Lee KY, et al
    Serine 235 Is the Primary NS5A Hyper-Phosphorylation Site Responsible for HCV Replication.
    J Virol. 2017 Apr 26. pii: JVI.00194-17. doi: 10.1128/JVI.00194.
    PubMed     Text format     Abstract available


  15. FAN H, Qiao L, Kang KD, Fan J, et al
    Attachment and Post-Attachment Receptors Important for Hepatitis C Virus Infection and Cell-to-Cell Transmission.
    J Virol. 2017 Apr 12. pii: JVI.00280-17. doi: 10.1128/JVI.00280.
    PubMed     Text format     Abstract available


    March 2017
  16. MORENO E, Gallego I, Gregori J, Lucia-Sanz A, et al
    Internal disequilibria and phenotypic diversification during replication of hepatitis C virus in a non-coevolving cellular environment.
    J Virol. 2017 Mar 8. pii: JVI.02505-16. doi: 10.1128/JVI.02505.
    PubMed     Text format     Abstract available


  17. OJIRO K, Qu X, Cho H, Park JJ, et al
    Modulation of HCV-specific CD8 effector T-cell function with antiviral effect in infectious hepatitis C virus co-culture model.
    J Virol. 2017 Mar 8. pii: JVI.02129-16. doi: 10.1128/JVI.02129.
    PubMed     Text format     Abstract available


    February 2017
  18. BALASIDDAIAH A, Davanian H, Aleman S, Pasetto A, et al
    Hepatitis C Virus-Specific T Cell Receptor mRNA-engineered Human T Cells: Impact of Antigen-Specificity on Functional Properties.
    J Virol. 2017 Feb 22. pii: JVI.00010-17. doi: 10.1128/JVI.00010.
    PubMed     Text format     Abstract available


  19. HADDAD J, Rouille Y, Hanoulle X, Descamps V, et al
    Identification of novel functions for hepatitis C virus envelope glycoprotein E1 in virus entry and assembly.
    J Virol. 2017 Feb 8. pii: JVI.00048-17. doi: 10.1128/JVI.00048.
    PubMed     Text format     Abstract available


  20. FREEDMAN H, Logan MR, Hockman D, Leman JK, et al
    Computational prediction of the heterodimeric and higher order structure of gpE1/gpE2 envelope glycoproteins encoded by the hepatitis C virus (HCV).
    J Virol. 2017 Feb 1. pii: JVI.02309-16. doi: 10.1128/JVI.02309.
    PubMed     Text format     Abstract available


    January 2017
  21. TONG Y, Chi X, Yang W, Zhong J, et al
    Functional analysis of HCV envelope protein E1 using a trans-complementation system reveals a dual role of a putative fusion peptide of E1 in both HCV entry and morphogenesis.
    J Virol. 2017 Jan 18. pii: JVI.02468-16. doi: 10.1128/JVI.02468.
    PubMed     Text format     Abstract available


  22. DEVHARE PB, Sasaki R, Shrivastava S, Di Bisceglie AM, et al
    Exosome mediated intercellular communication between hepatitis C virus infected hepatocytes and hepatic stellate cells.
    J Virol. 2017 Jan 11. pii: JVI.02225-16. doi: 10.1128/JVI.02225.
    PubMed     Text format     Abstract available


  23. HO CK, Raghwani J, Koekkoek S, Liang RH, et al
    Characterization of HCV envelope diversification from acute to chronic infection using SMRT sequencing within a sexually-transmitted hepatitis C virus cluster.
    J Virol. 2017 Jan 11. pii: JVI.02262-16. doi: 10.1128/JVI.02262.
    PubMed     Text format     Abstract available


  24. YAN Y, He Y, Boson B, Wang X, et al
    A point mutation in the N-terminal amphiphathic helix alpha0 in NS3 promotes HCV assembly by altering core localization to ER and facilitating virus budding.
    J Virol. 2017 Jan 4. pii: JVI.02399-16. doi: 10.1128/JVI.02399.
    PubMed     Text format     Abstract available


  25. WALTER S, Rasche A, Moreira-Soto A, Pfaender S, et al
    Differential Infection Patterns and Recent Evolutionary Origins of Equine Hepaciviruses in Donkeys.
    J Virol. 2016;91.
    PubMed     Text format     Abstract available


    December 2016
  26. MCCAFFREY K, Boo I, Owczarek CM, Hardy MP, et al
    An optimized hepatitis C virus E2 glycoprotein core adopts a functional homodimer that efficiently blocks virus entry.
    J Virol. 2016 Dec 28. pii: JVI.01668-16. doi: 10.1128/JVI.01668.
    PubMed     Text format     Abstract available


  27. DING Q, von Schaewen M, Hrebikova G, Heller B, et al
    Mice expressing minimally humanized CD81 and occludin genes support hepatitis C virus uptake in vivo.
    J Virol. 2016 Dec 7. pii: JVI.01799.
    PubMed     Text format     Abstract available


  28. MURAYAMA A, Sugiyama N, Suzuki R, Moriyama M, et al
    Amino Acid Mutations in the NS4A Region of Hepatitis C Virus Contribute to Viral Replication and Infectious Virus Production.
    J Virol. 2016 Dec 7. pii: JVI.02124.
    PubMed     Text format     Abstract available


    November 2016
  29. PHAM TM, Tran SC, Lim YS, Hwang SB, et al
    Hepatitis C Virus-Induced Rab32 Aggregation and its Implication in Virion Assembly.
    J Virol. 2016 Nov 16. pii: JVI.01662.
    PubMed     Text format     Abstract available


  30. ZHAO F, Zhao T, Deng L, Lv D, et al
    Visualizing the essential role of complete virion assembly machinery in efficient hepatitis C virus cell-to-cell transmission by viral infection activated split-intein mediated reporter system (VISI).
    J Virol. 2016 Nov 16. pii: JVI.01720.
    PubMed     Text format     Abstract available


  31. PIETSCHMANN T
    Clinically approved ion channel inhibitors close gates for hepatitis C virus -and open doors for drug repurposing in viral infectious diseases.
    J Virol. 2016 Nov 2. pii: JVI.01914.
    PubMed     Text format     Abstract available


  32. WANG J, Qiao L, Hou Z, Luo G, et al
    TIM-1 promotes hepatitis C virus cell attachment and infection.
    J Virol. 2016 Nov 2. pii: JVI.01583.
    PubMed     Text format     Abstract available


    October 2016
  33. LOGAN M, Law J, Wong JA, Hockman D, et al
    Native folding of a recombinant gpE1/gpE2 heterodimer vaccine antigen from a precursor protein fused with Fc IgG.
    J Virol. 2016 Oct 19. pii: JVI.01552.
    PubMed     Text format     Abstract available


  34. ELGNER F, Ren H, Medvedev R, Ploen D, et al
    The intra-cellular cholesterol transport inhibitor U18666A inhibits the exosome-dependent release of mature hepatitis C virus.
    J Virol. 2016 Oct 5. pii: JVI.01053.
    PubMed     Text format     Abstract available


    September 2016
  35. CHAN ST, Lee J, Narula M, Ou JJ, et al
    Suppression of Host Innate Immune Response by Hepatitis C Virus via the Induction of Autophagic Degradation of TRAF6.
    J Virol. 2016 Sep 28. pii: JVI.01365.
    PubMed     Text format     Abstract available


  36. BAYER K, Banning C, Bruss V, Wiltzer-Bach L, et al
    Hepatitis C virus is released via a non-canonical secretory route.
    J Virol. 2016 Sep 14. pii: JVI.01615.
    PubMed     Text format     Abstract available


  37. LI D, von Schaewen M, Wang X, Tao W, et al
    Altered glycosylation patterns increase immunogenicity of a subunit HCV vaccine inducing neutralizing antibodies which confer protection in mice.
    J Virol. 2016 Sep 14. pii: JVI.01462.
    PubMed     Text format     Abstract available


  38. ZUIANI A, Chen K, Schwarz MC, White JP, et al
    An E2 gene infectious HCV library reveals growth adaptive mutations that modulate interactions with the scavenger receptor class B type I.
    J Virol. 2016 Sep 14. pii: JVI.01011.
    PubMed     Text format     Abstract available


    August 2016
  39. YI Z, Fang C, Zou J, Xu J, et al
    Affinity purification of the Hepatitis C virus replicase identifies Valosin-containing protein (VCP) AAA+ATPase as an active viral replication modulator.
    J Virol. 2016 Aug 24. pii: JVI.01140.
    PubMed     Text format     Abstract available


  40. YANG Z, Wang X, Chi X, Zhao F, et al
    Neglected but Important Role of Apolipoprotein E Exchange in Hepatitis C Virus Infection.
    J Virol. 2016 Aug 17. pii: JVI.01353.
    PubMed     Text format     Abstract available


  41. WONG MT, Chen SS
    Human Choline Kinase-alpha Promotes Hepatitis C Virus RNA Replication through Modulating Membranous Viral Replication Complex Formation.
    J Virol. 2016 Aug 3. pii: JVI.00960.
    PubMed     Text format     Abstract available


  42. NAKAJIMA S, Watashi K, Ohashi H, Kamisuki S, et al
    Fungal-derived neoechinulin B as a novel antagonist of liver X receptor, identified by chemical genetics using hepatitis C virus cell culture system.
    J Virol. 2016 Aug 3. pii: JVI.00856.
    PubMed     Text format     Abstract available


    July 2016
  43. PUIG-BASAGOITI F, Fukuhara T, Tamura T, Ono C, et al
    Human cathelicidin compensates for the role of apolipoproteins in the infectious particle formation of HCV.
    J Virol. 2016 Jul 20. pii: JVI.00471.
    PubMed     Text format     Abstract available


  44. VAUSSELIN T, Seron K, Lavie M, Mesalam AA, et al
    Identification of a new benzimidazole derivative as an antiviral against hepatitis C virus.
    J Virol. 2016 Jul 13. pii: JVI.00404.
    PubMed     Text format     Abstract available


  45. ZHU S, Li T, Liu B, Xu Y, et al
    Infection of common marmosets with GB virus B chimeric virus encoding for the major nonstructural proteins NS2-4A of hepatitis C virus.
    J Virol. 2016 Jul 6. pii: JVI.02653.
    PubMed     Text format     Abstract available


    June 2016
  46. COLMAN H, Berre-Scoul CL, Hernandez C, Pierredon S, et al
    Correction for Colman et al., Genome-Wide Analysis of Host mRNA Translation during Hepatitis C Virus Infection.
    J Virol. 2016;90:5846.
    PubMed     Text format    


  47. MACPARLAND SA, Ma XZ, Chen L, Khattar R, et al
    Lipopolysaccharide and Tumor Necrosis Factor Alpha Inhibit Interferon Signaling in Hepatocytes by Increasing Ubiquitin-Like Protease 18 (USP18) Expression.
    J Virol. 2016;90:5549-60.
    PubMed     Text format     Abstract available


  48. COWTON VM, Angus AG, Cole SJ, Markopoulou CK, et al
    Role of Conserved E2 Residue W420 in Receptor Binding and Hepatitis C Virus Infection.
    J Virol. 2016 Jun 8. pii: JVI.00685.
    PubMed     Text format     Abstract available


  49. BISWAS A, Treadaway J, Tellinghuisen TL
    Interaction Between Non-Structural Proteins NS4B And NS5A Is Essential For Proper NS5A Localization And Hepatitis C Virus RNA Replication.
    J Virol. 2016 Jun 1. pii: JVI.00037.
    PubMed     Text format     Abstract available


  50. TRAN SC, Pham TM, Nguyen LN, Park EM, et al
    Nonstructural 3 protein of hepatitis C virus modulates tribbles homolog 3/Akt signaling pathway for persistent viral infection.
    J Virol. 2016 Jun 1. pii: JVI.00326.
    PubMed     Text format     Abstract available


    May 2016
  51. MANKOURI J, Walter C, Stewart H, Bentham M, et al
    Release of infectious hepatitis C virus from Huh7 cells occurs via a trans-Golgi network to endosome pathway independent of VLDL.
    J Virol. 2016 May 25. pii: JVI.00826.
    PubMed     Text format     Abstract available


  52. XUE B, Yang D, Wang J, Xu Y, et al
    ISG12a restricts hepatitis C virus infection through ubiquitination-dependent degradation pathway.
    J Virol. 2016 May 18. pii: JVI.00352.
    PubMed     Text format     Abstract available


  53. WALTER S, Bollenbach A, Doerrbecker J, Pfaender S, et al
    Ion Channel Function and Cross-Species Determinants in Viral Assembly of Nonprimate Hepacivirus p7.
    J Virol. 2016;90:5075-89.
    PubMed     Text format     Abstract available


  54. BANDIERA S, Pernot S, El Saghire H, Durand SC, et al
    HCV-induced up-regulation of miR-146a-5p in hepatocytes promotes viral infection and deregulates metabolic pathways associated with liver disease pathogenesis.
    J Virol. 2016 May 4. pii: JVI.00619.
    PubMed     Text format     Abstract available


    April 2016
  55. VEGNA S, Gregoire D, Moreau M, Lassus P, et al
    NOD1 participates in the innate immune response triggered by the hepatitis C viral polymerase.
    J Virol. 2016 Apr 20. pii: JVI.03230.
    PubMed     Text format     Abstract available


  56. REN H, Elgner F, Jiang B, Himmelsbach K, et al
    The autophagosomal SNARE protein syntaxin 17 is an essential factor for the hepatitis C virus life cycle.
    J Virol. 2016 Apr 20. pii: JVI.00551.
    PubMed     Text format     Abstract available


    March 2016
  57. BIEGEL JM, Pager CT
    Hepatitis C Virus Exploitation of Processing Bodies.
    J Virol. 2016 Mar 2. pii: JVI.03056.
    PubMed     Text format     Abstract available


    February 2016
  58. SWANN RE, Cowton VM, Robinson MW, Cole SJ, et al
    Broad anti-HCV antibody responses are associated with improved clinical disease parameters in chronic HCV infection.
    J Virol. 2016 Feb 24. pii: JVI.02669.
    PubMed     Text format     Abstract available


  59. LEE EM, Alsagheir A, Wu X, Hammack C, et al
    Hepatitis C virus induced degradation of cell death-inducing DFFA-like effector B leads to hepatic lipid dysregulation.
    J Virol. 2016 Feb 10. pii: JVI.02891.
    PubMed     Text format     Abstract available


    January 2016
  60. WASILEWSKI LN, El-Diwany R, Munshaw S, Snider AE, et al
    A hepatitis C virus envelope polymorphism confers resistance to neutralization by polyclonal sera and broadly neutralizing monoclonal antibodies.
    J Virol. 2016 Jan 27. pii: JVI.02837.
    PubMed     Text format     Abstract available


  61. SANDOMENICO A, Leonardi A, Berisio R, Sanguigno L, et al
    Generation and characterization of monoclonal antibodies against a cyclic variant of Hepatitis C Virus E2 epitope 412-422.
    J Virol. 2016 Jan 27. pii: JVI.02397.
    PubMed     Text format     Abstract available


  62. KONG L, Fujimoto A, Nakamura M, Aoyagi H, et al
    Prolactin regulatory element binding protein is involved in hepatitis C virus replication compartment by interacting with NS4B.
    J Virol. 2016 Jan 6. pii: JVI.01540.
    PubMed     Text format     Abstract available


  63. KECK ZY, Girard-Blanc C, Wang W, Lau P, et al
    Antibody response to the hypervariable region-1 interferes with broadly neutralizing antibodies to hepatitis C virus.
    J Virol. 2016 Jan 6. pii: JVI.02458.
    PubMed     Text format     Abstract available


    December 2015
  64. PALMER BA, Schmidt-Martin D, Dimitrova Z, Skums P, et al
    Network analysis of the chronic Hepatitis C virome defines HVR1 evolutionary phenotypes in the context of humoral immune responses.
    J Virol. 2015 Dec 30. pii: JVI.02995.
    PubMed     Text format     Abstract available


  65. GOMES R, Isken O, Tautz N, McLauchlan J, et al
    Polyprotein driven formation of two interdependent sets of complexes supporting hepatitis C virus genome replication.
    J Virol. 2015 Dec 30. pii: JVI.01931.
    PubMed     Text format     Abstract available


  66. TRAN GV, Luong TT, Park EM, Kim JW, et al
    Nonstructural 5A Protein of Hepatitis C Virus Regulates Soluble Resistance-related Calcium-binding Protein Activity for Viral Propagation.
    J Virol. 2015 Dec 30. pii: JVI.02493.
    PubMed     Text format     Abstract available


  67. JEE MH, Hong KY, Park JH, Lee JS, et al
    A new mechanism of hepatic fibrogenesis: hepatitis C virus infection induces TGF-beta1 production through glucose-regulated protein 94.
    J Virol. 2015 Dec 30. pii: JVI.02976.
    PubMed     Text format     Abstract available


  68. URBANOWICZ RA, McClure CP, Brown RJ, Tsoleridis T, et al
    A diverse panel of Hepatitis C Virus glycoproteins for use in vaccine research reveals extremes of monoclonal antibody neutralization resistance.
    J Virol. 2015 Dec 23. pii: JVI.02700.
    PubMed     Text format     Abstract available


  69. YU R, Yang D, Lei S, Wang X, et al
    HMGB1 promotes hepatitis C virus replication by interaction with the stem-loop 4 in viral 5' untranslated region.
    J Virol. 2015 Dec 9. pii: JVI.02795.
    PubMed     Text format     Abstract available


  70. ELSEBAI MF, Koutsoudakis G, Saludes V, Perez-Vilaro G, et al
    Pan-genotypic hepatitis C virus inhibition by natural products derived from the wild Egyptian artichoke.
    J Virol. 2015 Dec 9. pii: JVI.02030.
    PubMed     Text format     Abstract available


    November 2015
  71. SHRIVASTAVA S, Devhare P, Sujijantarat N, Steele R, et al
    Knockdown of autophagy inhibits infectious hepatitis C virus release by exosomal pathway.
    J Virol. 2015 Nov 18. pii: JVI.02383.
    PubMed     Text format     Abstract available


  72. DOUAM F, Bobay LM, Maurin G, Fresquet J, et al
    Specialization of hepatitis C virus envelope glycoproteins for B-lymphocytes in chronically infected patients.
    J Virol. 2015 Nov 4. pii: JVI.02516.
    PubMed     Text format     Abstract available


  73. KLEMENS O, Dubrau D, Tautz N
    Characterization of the Determinants of NS2-3-Independent Virion Morphogenesis of Pestiviruses.
    J Virol. 2015;89:11668-80.
    PubMed     Text format     Abstract available


    October 2015
  74. LI H, Stoddard M, Wang S, Giorgi EE, et al
    Single Genome Sequencing of Hepatitis C Virus in Donor-Recipient Pairs Distinguishes Modes and Models of Virus Transmission and Early Diversification.
    J Virol. 2015 Oct 14. pii: JVI.02156.
    PubMed     Text format     Abstract available


  75. YI G, Wen Y, Shu C, Han Q, et al
    The Hepatitis C Virus NS4B Can Suppress STING Accumulation to Evade Innate Immune Responses.
    J Virol. 2015 Oct 14. pii: JVI.01720.
    PubMed     Text format     Abstract available


  76. OHTSUKI T, Kimura K, Tokunaga Y, Tsukiyama-Kohara K, et al
    M2 macrophages play critical roles in progression of inflammatory liver disease in hepatitis C virus transgenic mice.
    J Virol. 2015 Oct 14. pii: JVI.02293.
    PubMed     Text format     Abstract available


  77. WALKER A, Skibbe K, Steinmann E, Pfaender S, et al
    Distinct escape pathway by HCV genotype 1a from a dominant CD8+ T cell response by selection of altered epitope processing.
    J Virol. 2015 Oct 7. pii: JVI.01993.
    PubMed     Text format     Abstract available


    September 2015
  78. MARNATA C, Saulnier A, Mompelat D, Krey T, et al
    Determinants involved in hepatitis C virus and GB virus B primate host restriction.
    J Virol. 2015 Sep 23. pii: JVI.01161.
    PubMed     Text format     Abstract available


  79. ALHAMMAD Y, Gu J, Boo I, Harrison D, et al
    Monoclonal antibodies directed towards the Hepatitis C virus glycoprotein E2 detect antigenic differences modulated by HVR1, HVR2 and the igVR.
    J Virol. 2015 Sep 16. pii: JVI.02070.
    PubMed     Text format     Abstract available


  80. WANG WT, Tsai TY, Chao CH, Lai BY, et al
    YB-1 Stabilizes Hepatitis C Virus NS5A via Phosphorylation-Mediated Interaction with NS5A to Regulate Viral Propagation.
    J Virol. 2015 Sep 9. pii: JVI.01513.
    PubMed     Text format     Abstract available


  81. ALIGETI M, Roder A, Horner SM
    Cooperation between the hepatitis C virus p7 and NS5B proteins enhances virion infectivity.
    J Virol. 2015 Sep 9. pii: JVI.01185.
    PubMed     Text format     Abstract available


  82. KWON YC, Bose SK, Steele R, Meyer K, et al
    PROMOTION OF CANCER STEM-LIKE CELL PROPERTIES IN HEPATITIS C VIRUS INFECTED HEPATOCYTES.
    J Virol. 2015 Sep 9. pii: JVI.01946.
    PubMed     Text format     Abstract available


  83. SHWETHA S, Kumar A, Mullick R, Vasudevan D, et al
    HuR displaces PTB to facilitate La binding to the 3' UTR and enhances HCV replication.
    J Virol. 2015 Sep 2. pii: JVI.01714.
    PubMed     Text format     Abstract available


    August 2015
  84. MCNAUGHTON AL, Cameron ID, Wignall-Fleming EB, Biek R, et al
    Spatiotemporal reconstruction of the introduction of hepatitis C virus into Scotland and its subsequent regional transmission.
    J Virol. 2015 Aug 26. pii: JVI.02106.
    PubMed     Text format     Abstract available


  85. KELL A, Stoddard M, Li H, Marcotrigiano J, et al
    PAMP Recognition of Hepatitis C Virus Transmitted/founder Variants by RIG-I is dependent on U-Core length.
    J Virol. 2015 Aug 26. pii: JVI.01964.
    PubMed     Text format     Abstract available


  86. GRUNVOGEL O, Esser-Nobis K, Reustle A, Schult P, et al
    Dead box helicase 60-like (DDX60L) is an interferon stimulated gene restricting hepatitis C virus replication in cell culture.
    J Virol. 2015 Aug 12. pii: JVI.01297.
    PubMed     Text format     Abstract available


  87. FALSON P, Bartosch B, Alsaleh K, Tews BA, et al
    Hepatitis C virus envelope glycoprotein E1 forms trimers at the surface of the virion.
    J Virol. 2015 Aug 5. pii: JVI.00991.
    PubMed     Text format     Abstract available


    July 2015
  88. PARK C, Min S, Park EM, Lim YS, et al
    Pim Kinase Interacts with Nonstructural 5A Protein and Regulates Hepatitis C Virus Entry.
    J Virol. 2015 Jul 22. pii: JVI.01707.
    PubMed     Text format     Abstract available


  89. GONDAR V, Molina-Jimenez F, Hishiki T, Garcia-Buey L, et al
    Apolipoprotein E, but not Apolipoprotein B, is essential for efficient HCV cell-to-cell transmission.
    J Virol. 2015 Jul 22. pii: JVI.00577.
    PubMed     Text format     Abstract available


  90. CALLAND N, Sahuc ME, Belouzard S, Pene V, et al
    Polyphenols Inhibit Hepatitis C Virus Entry by a New Mechanism of Action.
    J Virol. 2015 Jul 22. pii: JVI.01473.
    PubMed     Text format     Abstract available


  91. MARTINEZ MA, Nevot M, Jordan-Paiz A, Franco S, et al
    Similarities between HIV-1 and HCV genetic and phenotypic protease quasispecies diversity.
    J Virol. 2015 Jul 15. pii: JVI.01097.
    PubMed     Text format     Abstract available


  92. EL-DIWANY R, Wasilewski L, Witwer KW, Bailey JR, et al
    Acute Hepatitis C Virus Infection Induces Consistent Changes in Circulating miRNAs that are Associated with Non-Lytic Hepatocyte Release.
    J Virol. 2015 Jul 8. pii: JVI.00955.
    PubMed     Text format     Abstract available


  93. BAECHLEIN C, Fischer N, Grundhoff A, Alawi M, et al
    Identification of a Novel Hepacivirus in Domestic Cattle from Germany.
    J Virol. 2015;89:7007-15.
    PubMed     Text format     Abstract available


    June 2015
  94. BUKH J, Engle RE, Faulk K, Wang RY, et al
    Immunoglobulin with High-Titer In-vitro Cross Neutralizing Hepatitis C Virus Antibody Passively Protects Chimpanzee from Homologous, but not Heterologous Challenge.
    J Virol. 2015 Jun 17. pii: JVI.01194.
    PubMed     Text format     Abstract available


  95. ZHANG S, Bakshi RK, Suneetha PV, Fytili P, et al
    Frequency, private specificity and cross-reactivity of pre-existing HCV-specific CD8+ T cells in HCV seronegative individuals: implication for vaccine responses.
    J Virol. 2015 Jun 3. pii: JVI.00539.
    PubMed     Text format     Abstract available


  96. FENEANT L, Potel J, Francois C, Sane F, et al
    New insights into the understanding of hepatitis C virus entry and cell-to-cell transmission by using the ionophore Monensin A.
    J Virol. 2015 Jun 3. pii: JVI.00192.
    PubMed     Text format     Abstract available


  97. CORMAN VM, Grundhoff A, Baechlein C, Fischer N, et al
    Highly divergent hepaciviruses from African cattle.
    J Virol. 2015;89:5876-82.
    PubMed     Text format     Abstract available


    May 2015
  98. GUMMOW J, Li Y, Yu W, Garrod T, et al
    A multi-antigenic DNA vaccine that induces broad HCV-specific T-cell responses in mice.
    J Virol. 2015 May 27. pii: JVI.00803.
    PubMed     Text format     Abstract available


  99. DIXIT U, Pandey AK, Liu Z, Kumar S, et al
    FUSE Binding Protein1 Facilitates Persistent Hepatitis C Virus Replication in Hepatoma Cells by Regulating Tumor Suppressor p53.
    J Virol. 2015 May 20. pii: JVI.00729.
    PubMed     Text format     Abstract available


  100. MATHIESEN CK, Prentoe J, Meredith LW, Jensen TB, et al
    Adaptive mutations enhance assembly and cell-to-cell transmission of a high-titer hepatitis C virus genotype 5a Core-NS2 JFH1-based recombinant.
    J Virol. 2015 May 20. pii: JVI.00039.
    PubMed     Text format     Abstract available


  101. XIONG W, Yang J, Wang M, Wang H, et al
    Vinexin beta interacts with Hepatitis C Virus NS5A modulating its hyperphosphorylation to regulate viral propagation.
    J Virol. 2015 May 13. pii: JVI.00567.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis C is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: